SMTL ID : 6o8u.1 (3 other biounits)

Crystal structure of IRAK4 in complex with compound 23

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x LS7: N-[2,2-dimethyl-6-(morpholin-4-yl)-2,3-dihydro-1-benzofuran-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide(Non-covalent)

LS7.1: 15 residues within 4Å: Chain A: I.27, M.34, G.35, V.42, A.53, Y.104, V.105, Y.106, M.107, P.108, G.110, S.111, A.157, L.160, D.171 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:I.27, A:M.34, A:A.53, A:Y.106, A:L.160 Hydrogen bonds: A:M.107

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 1 residues within 4Å: Chain A: K.290 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:K.290

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.3: 6 residues within 4Å: Chain A: L.113, Y.196, E.221, P.227, A.228, V.229 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:S.156, A:Y.196, A:A.228, A:V.229, A:V.229

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bryan, M.C. et al., Development of Potent and Selective Pyrazolopyrimidine IRAK4 Inhibitors. J.Med.Chem. (2019)

Release Date

2019-05-22

Peptides

Interleukin-1 receptor-associated kinase 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Interleukin-1 receptor-associated kinase 4

Related Entries With Identical Sequence